• news.cision.com/
  • Getinge/
  • Servo-air® Launches in the U.S. Addressing Increased Need for Options and Flexibility for Patients and Hospitals

Servo-air® Launches in the U.S. Addressing Increased Need for Options and Flexibility for Patients and Hospitals

Report this content

The Servo-air® ventilator, for use in adult and pediatric patients, is designed to be mobile and easy to use and is available now in the U.S.  The new ventilator addresses multiple needs of COVID-19 treatment centers including mobility and flexibility, by being independent from wall-based gas units, possessing a hot-swappable battery and having the ability to travel with patients as they are transferred intra-hospital.

 

Today, Getinge launches Servo-air, a high performing ventilator intended for adult and pediatric patients in the United States. Servo-air includes both Invasive and Non-Invasive (NIV) ventilation modes, with Getinge’s unique High Flow Therapy and Servo Compass® options. Designed for mobility, Servo-air does not require wall-gas and utilizes “hot-swappable” battery technology to switch power sources without restarting the unit. The included software modes allow clinicians to adapt and personalize ventilation to the patient and situation.

The COVID-19 health crisis has underscored the need for personalized ventilation for critically ill patients.  As the number of coronavirus cases in the U.S. increased, the demand for and pressure on the availability of ventilation machines was highlighted. That demand, coupled with the emergence of pop-up hospitals to treat the influx of patients, has made portable, easy to operate ventilators an increasingly important requirement. 

“At the start of the COVID-19 pandemic, Getinge responded by increasing our ventilator production by 160% to help offset the rapidly growing need for these machines. We are proud to introduce our latest model, which will create flexibility for hospitals, easy transportation for pop-up treatment centers and personalization in patient treatment,” said Eric Honroth, President, Getinge North America.

Servo-air will provide clinicians with a much-needed, mobile additional option. The high-performing ventilator is turbine-driven, which can be transferred intra-hospital with the patient, allowing the continuation of life-saving ventilatory support without having to switch devices. Servo-air also operates with intuitive start-up and personalization of settings. Additionally, the Servo Compass interface provides continuous monitoring and tools for supporting critical lung-protective strategies. As the patient’s condition improves, Servo-air’s Automode® switches between controlled and supported ventilation depending on patient effort, providing a smoother patient transition to spontaneous breathing with less staff intervention, which is safe for the patient and is less burden on the medical center.

For more than 50 years, Getinge has produced high-acuity ventilators such as the Servo-u and Servo-n, and technologies that help neonates and adults breathe including NAVA and NIV.

Servo-air is a high acuity, versatile, intuitive and powerful ventilator that supports the needs of critically-ill patients. To read more about our latest innovations and our full line of mechanical ventilatory support offerings, visit our website.

Media contact:

Ampy Vasquez
Director, Marketing Communications
862-221-4626
Amparo.vasquez@getinge.com

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.

Tags:

Subscribe

Media

Media